• 1. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
• 2. Evolutionary de novo design of phenothiazine derivatives for dye-sensitized solar cells?
  Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
• 3. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 4. Evidence for the intrinsic nature of band-gap states electrochemically observed on atomically flat TiO2(110) surfaces?
  Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Phenylquinolines

Professional Introduction to 3-(3-Fluoro-phenyl)-quinoline (CAS No. 181421-88-5)

3-(3-Fluoro-phenyl)-quinoline, identified by the Chemical Abstracts Service Number (CAS No.) 181421-88-5, is a significant compound in the realm of pharmaceutical chemistry and medicinal research. This heterocyclic aromatic molecule has garnered considerable attention due to its unique structural properties and promising biological activities. The presence of a fluoro substituent in the phenyl ring introduces electronic and steric effects that can modulate the compound's interactions with biological targets, making it a valuable scaffold for drug discovery.

The quinoline core is well-documented for its pharmacological relevance, with numerous derivatives exhibiting antimicrobial, antimalarial, and anticancer properties. The introduction of a fluoro-substituted phenyl ring in 3-(3-Fluoro-phenyl)-quinoline enhances its potential as a lead compound in developing novel therapeutic agents. Recent studies have highlighted the importance of fluorine atoms in medicinal chemistry, as they can improve metabolic stability, binding affinity, and overall pharmacokinetic profiles of drug candidates.

In the context of contemporary pharmaceutical research, 3-(3-Fluoro-phenyl)-quinoline has been investigated for its potential applications in addressing various diseases. For instance, its structural motif is reminiscent of several known bioactive molecules that target specific enzymes or receptors involved in pathogenic processes. The fluorine atom's ability to influence electronic properties makes it particularly useful in designing molecules that can selectively interact with biological targets, thereby reducing off-target effects and enhancing therapeutic efficacy.

A notable area of research involving 3-(3-Fluoro-phenyl)-quinoline is its role in anticancer therapy. Quinoline derivatives have long been explored for their cytotoxic effects on cancer cells, and the modification with a fluoro-substituted phenyl ring may further enhance these properties. Preliminary studies suggest that this compound can induce apoptosis in certain cancer cell lines by inhibiting key signaling pathways involved in tumor growth and survival. The precise mechanism of action remains an active area of investigation, but the preliminary findings are encouraging for future clinical applications.

The synthesis of 3-(3-Fluoro-phenyl)-quinoline presents an interesting challenge due to the need to carefully control reaction conditions to achieve high yields and purity. Advanced synthetic methodologies, such as transition metal-catalyzed cross-coupling reactions and palladium-mediated transformations, have been employed to construct the desired molecular framework efficiently. These synthetic strategies not only highlight the versatility of modern organic chemistry but also underscore the importance of optimizing reaction conditions to produce compounds with desired pharmacological properties.

The pharmacokinetic behavior of 3-(3-Fluoro-phenyl)-quinoline is another critical aspect that has been extensively studied. Fluorinated aromatic compounds are known for their improved bioavailability and prolonged half-life in vivo, which can translate into more effective therapeutic outcomes. Computational modeling and experimental techniques have been utilized to evaluate the metabolic stability and distribution of this compound within biological systems. Such studies provide valuable insights into how structural modifications can influence drug disposition and efficacy.

In conclusion, 3-(3-Fluoro-phenyl)-quinoline strong>, with its CAS No. 181421-88-5, represents a promising candidate for further development in pharmaceutical applications. Its unique structural features and demonstrated biological activities make it a compelling subject for ongoing research. As our understanding of molecular interactions continues to evolve, compounds like this one will play a crucial role in shaping the future of drug discovery and development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)